Cost-effectiveness Analysis of Five Therapeutic Schemes for Female's Urogenital Tract Infections of Gon-ococcus Combining Chlamydia
- VernacularTitle:5种治疗女性泌尿生殖道淋球菌合并衣原体感染方案的成本-效果分析
- Author:
Qian WANG
;
Yancong ZHANG
;
Yunfeng DENG
- Publication Type:Journal Article
- Keywords:
urogenital disease;
infection of gonococcus combining chlamydia;
pharmacoeconomics;
cost-effectiveness analysis
- From:
China Pharmacy
1991;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To discuss the economic effectiveness of different therapeutic schemes for the same disease.METH_ODS:104 cases of female's urogenital tract infections of gonococcus combining chlamydia were randomly divided into five gro_ups,which were given ofloxacin(A),levofloxacin hydrochloride(B),clarithromycin(C),azithromycin(D)and ceftriaxone+erythromycin(E)respectively.Using pharmacoeconomic cost-effectiveness analysis method,the five schemes were compared.RES_ULTS:The costs of the five schemes were RMB 351,390,474,633 and 666 yuans,respectively.The ratios between cost and effectiveness were 5.7,4.5,5.5,7.6 and 8.3 in term of curative rate and 4.9,4.1,5.2,7.1 and 7.8 in term of effective rate respectively.CONCLUSION: B and C schemes are the best ones.
